AOD9604 – 5mg

AOD-9604 is a synthetic peptide based on a short sequence from the C-terminal region of human growth hormone. It is a defined peptide fragment rather than the complete growth hormone molecule.

In practical research terms, this allows investigators to study the behaviour of a specific peptide sequence independently from the much larger parent hormone.

Pronoia supplies AOD-9604 as a 5mg lyophilised research material for controlled laboratory, analytical and experimental research applications.

Product: AOD-9604

Specification: 5mg

Material class: Synthetic peptide fragment

Form: Lyophilised solid

Minimum purity standard: ≥98%

Batch traceability: Maintained

Pronoia supplies AOD-9604 within its established research-material quality framework, with a minimum purity standard of ≥98% and batch traceability maintained throughout the product record.

Independent analytical testing supports product quality assessment, with batch-specific documentation retained to provide researchers with clearer traceability of the material being supplied.

Where a specific analytical testing method is documented for an individual batch, this should be confirmed from the corresponding Certificate of Analysis rather than assumed from general product information.

Certificate of Analysis (COA) and Safety Data Sheet (SDS) documentation are available.

AOD-9604 has been investigated as a defined hormone-derived peptide fragment in experimental research concerning metabolic regulation and lipid-related pathways.

Published laboratory and animal-model research has examined areas including lipid metabolism, fat oxidation, peptide signalling and the relationship between specific growth-hormone-derived sequences and broader metabolic pathways.

Its value as a research material lies in allowing investigators to examine a comparatively small, defined peptide fragment rather than studying the complete growth hormone molecule.

Research contexts may therefore include peptide structure–function studies, metabolic pathway investigation, cellular signalling research and comparative studies of hormone-derived peptide fragments.

AOD-9604 is supplied as a lyophilised research material and should be maintained under appropriate temperature-controlled storage conditions.

The vial should remain securely sealed and protected from unnecessary exposure to heat, moisture and light while in storage.

Researchers should follow the applicable batch documentation and their validated laboratory procedures when preparing, handling or storing the material for experimental work.

Pronoia supplies AOD-9604 through its tracked UK delivery service, with the product handled within the same controlled fulfilment process used across the Pronoia research range.

Batch traceability is maintained, with Certificate of Analysis (COA) and Safety Data Sheet (SDS) documentation available to support laboratory record keeping and material assessment.

Dispatch availability and applicable delivery conditions are shown directly on the product page and are subject to Pronoia’s current delivery terms.

AOD-9604 supplied by Pronoia Bio is intended strictly for controlled laboratory research, analytical investigation and experimental use.

It is not supplied for human or veterinary use and should not be treated as a medicine, food product or consumer supplement.

Purchasers are responsible for ensuring that the material is handled and used appropriately within their research environment and in accordance with applicable requirements.